Hanover, Germany

Tobias Weismueller

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Medizinische Hochschule Hannover, University of Alberta. Active years: 2017-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tobias Weismueller. Retrieved from https://idiyas.com/inventor/tobias-weismueller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Tobias Weismueller - Innovative Inventor from Hannover

Introduction: Tobias Weismueller is a renowned inventor hailing from Hannover, Germany, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Tobias Weismueller holds several recent patents in the areas of renewable energy technologies, sustainable materials, and advanced robotics, showcasing his commitment to developing solutions for the future.

Career Highlights: With a background in engineering and a passion for pushing the boundaries of technology, Tobias Weismueller has had a successful career marked by numerous awards and recognitions for his inventive work.

Collaborations: Throughout his career, Tobias Weismueller has collaborated with leading research institutions, universities, and companies worldwide to bring his ideas to life and make a positive impact on society.

Conclusion: Tobias Weismueller's dedication to innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the landscape of technological advancements globally.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…